What is respiratory syncytial virus? Expert offers advice - The Cincinnati Enquirer | Canada News Media
Connect with us

Health

What is respiratory syncytial virus? Expert offers advice – The Cincinnati Enquirer

Published

 on


Show Caption
Hide Caption

RSV: The breath-stealing virus that has New York scientists on the hunt for a vaccine

RSV, or respiratory syncytial virus, can be deadly to kids under 5 or adults over 65

Pfizer, Rockland/Westchester Journal News

Hospital emergency rooms here and across the country are swelling with young patients who are sick, including some struggling to breathe properly, as cases of respiratory syncytial virus, or RSV, climb and the indoor season begins to bring on other similar viruses.

Cincinnati Children’s Hospital Medical Center is alerting families to long wait times at emergency departments and encouraging them to contact their children’s pediatricians.

“Cincinnati Children’s Hospital is very busy,” said Dr. Felicia Scaggs Huang, associate director of infection prevention and control at the hospital. “We have more people admitted for respiratory illnesses than usual.”

She said the hospital has the capacity to take other admissions when appropriate. “We are not turning away any patients who require admission for respiratory illnesses. And we will always be working to provide high-quality care to our pediatric patients.”

We asked the experts:Should I get one of the new COVID-19 boosters?

More:At start of pandemic, kids’ routine immunizations lagged. Why are they still down?

We asked the doctor for tips for parents and other caregivers, who are keeping a close eye on their children’s noses and assessing for signs of difficulty breathing.

Q. What is respiratory syncytial virus?

A. Respiratory syncytial virus is a virus that most children have been exposed to by the time they’re 2 years old. Symptoms vary from just a mild cold to bronchiolitis, or inflammation of the small airways in the lungs, or pneumonia. A lot of children were not exposed to RSV in the past couple of years because the COVID-19 pandemic changed how people interacted. So a lot of kids are getting RSV now because it’s the first time their immune system has encountered it.

Q. Is RSV on the rise?

A. We are seeing more respiratory illness-related admissions overall as well as an increase in the number of positive RSV and influenza tests.

Q. How can I help my child avoid this virus?

A. The virus is contracted through respiratory droplets and contact with surfaces that have these droplets on them. Go with the usual prevention strategies: Wash your hands thoroughly and frequently with soap and water. Keep your hands off your face. Avoid close contact with those who are sick. Disinfect surfaces. If you are sick, cover your mouth and nose when coughing or sneezing, wash your hands afterward, and stay home (or keep your children home).

Q. I heard it’s tough to recognize RSV. How can I know if my child has it?

A. The virus can be clinically indistinguishable from other respiratory viruses. In older kids, it often manifests as just a cold. Children who are less than 6 months old or who have chronic medical conditions like asthma can present with more severe symptoms. Over time, the virus can progress and involve the small airways in the lungs, which could cause wheezing, breathing fast, or looking uncomfortable while breathing. Young infants may have pauses in their breathing or apnea. If you see those symptoms, in addition to your child not eating and drinking enough, call your pediatrician. Focusing on the hydration status and work of breathing can also help determine if your child needs to get evaluated.

Q. How do hospitals treat the virus?

A. If a baby or child develops bronchiolitis – a wheezing-type illness that involves smaller airways in the lungs – or pneumonia, we treat it with what we call supportive care. So, providing oxygen if a child needs it. Often, these children have a lot of secretions, so we help suction them out. And we would give a child IV fluids if they need them. However, there aren’t antibiotics or antivirals that can help treat RSV at this time.

Q. Is there a vaccine to guard against the virus?

A. There is not currently a vaccine that is available to the general public for RSV unfortunately. At Cincinnati Children’s, we are working to develop a vaccine candidate for RSV to help prevent severe disease in children who are most at risk.

More: Vaccine for pregnant people?RSV vaccine during pregnancy could prevent life-threatening respiratory virus in infants

Q. What other respiratory illness may be on the rise?

A. Many experts are predicting overall we will have a very busy respiratory illness season. These experts are also predicting that we will see an increase in COVID-19 over the holiday season as families get together with relatives from out of town. Being up to date with your COVID-19 vaccination is very important. I have an infant and a toddler who are fully vaccinated against influenza and COVID-19, and I will get them boosted when they’re eligible. I think other parents should too.

Adblock test (Why?)



Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version